Mechanisms contributing to increased cardiovascular risk in patients taking proton pump inhibitors. [Cartal] (2017)
- Authors:
- USP affiliated authors: SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidades: FMRP
- DOI: 10.1111/nmo.12988
- Subjects: DOENÇAS VASCULARES; FARMACOLOGIA
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Neurogastroenterology & Motility
- ISSN: 1350-1925
- Volume/Número/Paginação/Ano: v. 29, n. 2, art. e12988, 2017
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
AMARAL, Jefferson Henrich; TANUS-SANTOS, José Eduardo. Mechanisms contributing to increased cardiovascular risk in patients taking proton pump inhibitors. [Cartal]. Neurogastroenterology & Motility[S.l: s.n.], 2017.Disponível em: -
APA
Amaral, J. H., & Tanus-Santos, J. E. (2017). Mechanisms contributing to increased cardiovascular risk in patients taking proton pump inhibitors. [Cartal]. Neurogastroenterology & Motility. Oxford. doi:10.1111/nmo.12988 -
NLM
Amaral JH, Tanus-Santos JE. Mechanisms contributing to increased cardiovascular risk in patients taking proton pump inhibitors. [Cartal] [Internet]. Neurogastroenterology & Motility. 2017 ; 29( 2):Available from: http://dx.doi.org/10.1111/nmo.12988 -
Vancouver
Amaral JH, Tanus-Santos JE. Mechanisms contributing to increased cardiovascular risk in patients taking proton pump inhibitors. [Cartal] [Internet]. Neurogastroenterology & Motility. 2017 ; 29( 2):Available from: http://dx.doi.org/10.1111/nmo.12988 - eNOS polymorphism associated with metabolic syndrome in children and adolescents
- Xanthine oxidoreductase contributes to vasodillation and antihypertensive effects of sodium nitrite in renovascular hypertension
- The antioxidant tempol decreases acute pulmonary thromboembolism-induced hemolysis and nitric oxide consumption
- Nitrate decreases xanthine oxidoreductase-mediated nitrite reductase activity and attenuates vascular and blood pressure responses to nitrite
- eNOS gene polymorphirms may modify the effects produced by cardiovascular drugs on myocardial eNOS expression and activity [Carta]
- Effects of angiotensin-converting enzyme inhibition on leptin and adiponectin levels in essential hypertension
- Consistent antioxidant and antihypertensive effects of oral sodium nitrite in DOCA-salt hypertension
- Adiponectin -11377C/G and +276G/T polymorphisms affect adiponectin levels but not modify responsiveness to therapy in resistant hypertension
- Vascular damage in resistant hypertension: TNF-alpha inhibition effects on endothelial cells
- Elevated plasma hemoglobin levels increase nitric oxide consumption in experimental and clinical acute pulmonary thromboembolism
Informações sobre o DOI: 10.1111/nmo.12988 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
